Dynamic List Information
Dynamic List Data
Study Title
A Phase II Study of Induction Systemic mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone Given Concurrently With Systemic mFOLFIRI as a First-Line Therapy in Patients With Unresectable Liver-Dominant Intrahepatic Cholangiocarcinoma
Sponsor Name
OHSU Knight Cancer Institute
NCT Number
NCT04251715
IDE Number
G190104
CMS Approval Date
2020-10-01
Clinical Trial Link
Category
B